Whole-body MRI may help detect cardiovascular and cerebrovascular changes in patients with diabetes, allowing more aggressive management.
Whole-body MRI can help clinicians assess people with diabetes for increased risk of heart attacks or stroke, according to an article published in the journal Radiology.
Patients with diabetes are at increased risk of developing atherosclerosis, which contributes to major adverse cardiovascular and cerebrovascular events (MACCE), such as heart attack or stroke. By using whole-body MRI, clinicians may be able to identify patients at highest risk for such events and treat or observe them accordingly.
Researchers from Germany studied the predictive value among 65 patients with diabetes with follow-up information available on 61. The patients underwent a contrast-enhanced whole-body MRI protocol, including brain, cardiac, and vascular sequences.
The patients were followed for a median of 5.8 years. Fourteen patients experienced MACCE during this period. The researchers found that patients who had detectable vascular changes faced a cumulative MACCE risk rate of 20 percent at three years and 35 percent at six years. Patients who had normal MRI findings did not experience MACCE.
The researchers acknowledge that more study is needed as using whole-body MRI for such evaluations is relatively new. However, it is advantageous because it can assess patients over larger parts of the body without exposing them to radiation.
“Other established and valuable tools, such as myocardial perfusion imaging or computed tomography (CT) for quantification of coronary calcification, are generally limited to cardiac evaluation due to their associated risk profiles,” said researcher Fabian Bamberg, MD, MPH, in a release. “Also MRI provides unique insights into soft tissue pathology, including cerebral and vascular changes, such as restriction of blood flow to the brain.”
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.